v3.26.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   84,613      
Balance at beginning of period at Dec. 31, 2024 $ 516,283 $ 8 $ 886,823 $ (6,823) $ (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,761      
Common stock issued pursuant to equity awards, net 2,877 $ 1 2,876    
Stock-based compensation 22,871   22,871    
Other comprehensive income (loss) 857     857  
Net income (loss) (49,713)       (49,713)
Balance at end of period (in shares) at Mar. 31, 2025   86,374      
Balance at end of period at Mar. 31, 2025 493,175 $ 9 912,570 (5,966) (413,438)
Balance at beginning of period (in shares) at Dec. 31, 2024   84,613      
Balance at beginning of period at Dec. 31, 2024 516,283 $ 8 886,823 (6,823) (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (121,784)        
Balance at end of period (in shares) at Sep. 30, 2025   87,373      
Balance at end of period at Sep. 30, 2025 464,727 $ 9 950,067 160 (485,509)
Balance at beginning of period (in shares) at Mar. 31, 2025   86,374      
Balance at beginning of period at Mar. 31, 2025 493,175 $ 9 912,570 (5,966) (413,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   331      
Employee stock purchase plan (in shares)   202      
Employee stock purchase plan 2,178   2,178    
Stock-based compensation 13,264   13,264    
Other comprehensive income (loss) 6,300     6,300  
Net income (loss) (26,586)       (26,586)
Balance at end of period (in shares) at Jun. 30, 2025   86,907      
Balance at end of period at Jun. 30, 2025 488,331 $ 9 928,012 334 (440,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   466      
Common stock issued pursuant to equity awards, net 615   615    
Stock-based compensation 21,440   21,440    
Other comprehensive income (loss) (174)     (174)  
Net income (loss) (45,485)       (45,485)
Balance at end of period (in shares) at Sep. 30, 2025   87,373      
Balance at end of period at Sep. 30, 2025 $ 464,727 $ 9 950,067 160 (485,509)
Balance at beginning of period (in shares) at Dec. 31, 2025 86,451 86,451      
Balance at beginning of period at Dec. 31, 2025 $ 451,895 $ 9 951,262 1,030 (500,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   3,078      
Common stock issued pursuant to equity awards, net 28,360   28,360    
Stock-based compensation 19,982   19,982    
Other comprehensive income (loss) (909)     (909)  
Net income (loss) (45,137)       (45,137)
Balance at end of period (in shares) at Mar. 31, 2026   89,529      
Balance at end of period at Mar. 31, 2026 $ 454,191 $ 9 999,604 121 (545,543)
Balance at beginning of period (in shares) at Dec. 31, 2025 86,451 86,451      
Balance at beginning of period at Dec. 31, 2025 $ 451,895 $ 9 951,262 1,030 (500,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (14,475)        
Balance at end of period (in shares) at Sep. 30, 2026 91,000 91,000      
Balance at end of period at Sep. 30, 2026 $ 533,009 $ 9 1,047,240 641 (514,881)
Balance at beginning of period (in shares) at Mar. 31, 2026   89,529      
Balance at beginning of period at Mar. 31, 2026 454,191 $ 9 999,604 121 (545,543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   989      
Common stock issued pursuant to equity awards, net (1,758)   (1,758)    
Employee stock purchase plan (in shares)   174      
Employee stock purchase plan 1,961   1,961    
Stock-based compensation 27,458   27,458    
Other comprehensive income (loss) 1,228     1,228  
Net income (loss) 1,760       1,760
Balance at end of period (in shares) at Jun. 30, 2026   90,692      
Balance at end of period at Jun. 30, 2026 484,840 $ 9 1,027,265 1,349 (543,783)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   308      
Common stock issued pursuant to equity awards, net 164   164    
Stock-based compensation 19,811   19,811    
Other comprehensive income (loss) (708)     (708)  
Net income (loss) $ 28,902       28,902
Balance at end of period (in shares) at Sep. 30, 2026 91,000 91,000      
Balance at end of period at Sep. 30, 2026 $ 533,009 $ 9 $ 1,047,240 $ 641 $ (514,881)